Sunday, December 14, 2025

Latest

Mindcure Ends Fiscal Q1 2022 With $15.6 Million Cash & Cash Equivalents, $2.8 Million Net Loss

Mind Cure Health (CSE: MCUR) announced on Tuesday the financial results for the three months ended August 31, 2021. The firm ended the quarter with a $2.8 million net loss compared to fiscal Q1 2021’s net loss of $0.3 million.

Among the company’s expenses for the quarter include $1.0 million in consulting fees and payroll, $0.2 million worth of inventory write down, and $0.3 million in share-based payments. The quarterly loss translates to $0.03 per share.

On the other hand, the firm ended the quarter with a cash and cash equivalents balance of $15.6 million. This makes the current assets worth $16.4 million while the current liabilities came in at $1.3 million.

The firm also relayed that it has granted a total of 70,000 stock options to certain employees related to its long-term incentive plan.

Mind Cure Health last traded at $0.29 on the CSE.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Canada Has So Few Projects That Can Be Built Before 2030 | Dan Wilton – First Mining

Guanajuato Silver: Q3 Results Overshadowed By Silver Ripping

I Went to See the Highest Grade Silver on Earth | Nord Precious Metals

Recommended

Steadright Locks Up Goundafa Polymetallic Mine Under Binding MOU

Emerita Resources Awards Contract For Pre-Feasibility Study On Iberian Belt West Project

Related News

Mind Cure Signs LOI To Take Equity Stake In Psychedelic Treatment Centre

Mind Cure Health (CSE: MCUR) has signed a non-binding letter of intent to conduct a...

Tuesday, January 12, 2021, 07:41:53 AM

Mind Cure Health Begins Research Into Psychedelic Compounds

Mind Cure Health (CSE: MCUR) has reached a milestone, with the company this morning announcing...

Tuesday, December 8, 2020, 08:04:33 AM

Mind Cure Doubles Bought Deal Financing To $20 Million

Strong demand continues within the psychedelics space, with Mind Cure Health (CSE: MCUR) announcing earlier...

Friday, January 22, 2021, 02:07:33 PM

Psychedelics & The Need For Digital Therapeutic Solutions In Treating Mental Health

In terms of investment dollar inflows, one of the largest focuses of 2020 has arguably...

Sunday, November 1, 2020, 09:00:00 AM

Mind Cure Receives Health Canada Approval For Sale Of Moonbeam Mushroom Products

Mind Cure Health (CSE: MCUR) has received the required authorizations from Health Canada for its...

Wednesday, September 23, 2020, 08:33:06 AM